Aveanna Healthcare Hldgs Q2 2024 Adj. EPS $0.01 Beats $(0.02) Estimate, Sales $504.958M Beat $493.360M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aveanna Healthcare Holdings (NASDAQ: AVAH) reported Q2 2024 adjusted EPS of $0.01, beating the estimate of $(0.02) by 150%. Sales were $504.958M, surpassing the $493.360M estimate and showing a 7% increase from the same period last year.
August 08, 2024 | 10:32 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aveanna Healthcare Holdings reported better-than-expected Q2 2024 earnings and sales, with EPS of $0.01 beating the $(0.02) estimate and sales of $504.958M surpassing the $493.360M estimate. Sales increased by 7% year-over-year.
The better-than-expected earnings and sales figures, along with a 7% year-over-year sales increase, are likely to positively impact AVAH's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100